68 related articles for article (PubMed ID: 23245511)
1. Synthetic glycolipids for glioma growth inhibition developed from neurostatin and NF115 compound.
Doncel-Pérez E; García-Álvarez I; Fernández-Mayoralas A; Nieto-Sampedro M
Bioorg Med Chem Lett; 2013 Jan; 23(2):435-9. PubMed ID: 23245511
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of neurostatin-related compounds with high inhibitory activity of glioma growth.
Valle-Argos B; Gómez-Nicola D; Nieto-Sampedro M
Eur J Med Chem; 2010 May; 45(5):2034-43. PubMed ID: 20153569
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting human astrocytoma growth: structure-activity relationships in neurostatin related glycolipids.
Romero-Ramírez L; Nieto-Sampedro M
J Med Chem; 2004 Oct; 47(21):4983-4. PubMed ID: 15456241
[TBL] [Abstract][Full Text] [Related]
4. Neurostatin blocks glioma cell cycle progression by inhibiting EGFR activation.
Valle-Argos B; Gómez-Nicola D; Nieto-Sampedro M
Mol Cell Neurosci; 2011 Jan; 46(1):89-100. PubMed ID: 20801220
[TBL] [Abstract][Full Text] [Related]
5. Glioma growth inhibition by neurostatin and O-But GD1b.
Valle-Argos B; Gómez-Nicola D; Nieto-Sampedro M
Neuro Oncol; 2010 Nov; 12(11):1135-46. PubMed ID: 20615925
[TBL] [Abstract][Full Text] [Related]
6. Natural, synthetic and semisynthetic glycolipid inhibitors of glioma growth.
Nieto-Sampedro M; Doncel-Pérez E; Fernández-Mayoralas A
Expert Opin Ther Pat; 2004 Apr; 14(4):487-97. PubMed ID: 21793650
[TBL] [Abstract][Full Text] [Related]
7. [Neuronal glycolipids regulate glial cell division negatively during development and following a lesion].
Nieto-Sampedro M; Muneton-Gomez VC
Rev Neurol; 2017 Jun; 64(12):549-567. PubMed ID: 28608355
[TBL] [Abstract][Full Text] [Related]
8. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM
BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of antimitotic thioglycosides: in vitro and in vivo evaluation of their anticancer activity.
García-Álvarez I; Groult H; Casas J; Barreda-Manso MA; Yanguas-Casás N; Nieto-Sampedro M; Romero-Ramírez L; Fernández-Mayoralas A
J Med Chem; 2011 Oct; 54(19):6949-55. PubMed ID: 21866909
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of glycoside inhibitors of glioma and melanoma growth.
García-Alvarez I; Corrales G; Doncel-Pérez E; Muñoz A; Nieto-Sampedro M; Fernández-Mayoralas A
J Med Chem; 2007 Jan; 50(2):364-73. PubMed ID: 17228879
[TBL] [Abstract][Full Text] [Related]
11. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
[TBL] [Abstract][Full Text] [Related]
12. N-Aryl-N'-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: screening, synthesis of simplified derivatives, and structure-activity relationship analysis.
Goffin E; Lamoral-Theys D; Tajeddine N; de Tullio P; Mondin L; Lefranc F; Gailly P; Rogister B; Kiss R; Pirotte B
Eur J Med Chem; 2012 Aug; 54():834-44. PubMed ID: 22809560
[TBL] [Abstract][Full Text] [Related]
13. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
[TBL] [Abstract][Full Text] [Related]
14. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
15. Modulation of C6 Glioma Cell Proliferation by Ureido-Calix[8]arenes.
Viola S; Merlo S; Consoli GM; Drago F; Geraci C; Sortino MA
Pharmacology; 2010; 86(3):182-8. PubMed ID: 20720453
[TBL] [Abstract][Full Text] [Related]
16. Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation.
Mielcke TR; Mascarello A; Filippi-Chiela E; Zanin RF; Lenz G; Leal PC; Chiaradia LD; Yunes RA; Nunes RJ; Battastini AM; Morrone FB; Campos MM
Eur J Med Chem; 2012 Feb; 48():255-64. PubMed ID: 22209415
[TBL] [Abstract][Full Text] [Related]
17. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
Ryu JK; Jantaratnotai N; Serrano-Perez MC; McGeer PL; McLarnon JG
J Neuropathol Exp Neurol; 2011 Jan; 70(1):13-22. PubMed ID: 21157381
[TBL] [Abstract][Full Text] [Related]
18. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
[TBL] [Abstract][Full Text] [Related]
19. Detection of metabolite changes in C6 glioma cells cultured with antimitotic oleyl glycoside by 1H MAS NMR.
García-Alvarez I; Garrido L; Doncel-Pérez E; Nieto-Sampedro M; Fernández-Mayoralas A
J Med Chem; 2009 Mar; 52(5):1263-7. PubMed ID: 19199478
[TBL] [Abstract][Full Text] [Related]
20. Synthetic studies on glycosphingolipids from Protostomia phyla: synthesis of amphoteric glycolipid analogues containing a phosphocholine residue from the earthworm Pheretima hilgendorfi.
Hada N; Sato K; Sakushima JI; Goda Y; Sugita M; Takeda T
Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1464-7. PubMed ID: 11724239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
